Technical Analysis for NVCT - Nuvectis Pharma, Inc.

Grade Last Price % Change Price Change
A 19.0 0.80% 0.15
NVCT closed up 0.8 percent on Monday, May 16, 2022, on 32 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Up

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
NR7 Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
New 52 Week Closing High Bullish 0.80%
Upper Bollinger Band Walk Strength 0.80%
Wide Bands Range Expansion 0.80%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 8 hours ago
New 52 Week High about 10 hours ago
Down 3% about 10 hours ago
Up 5% about 10 hours ago
Down 2 % about 10 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of targeted small molecule therapeutics for the treatment of cancer. The company develops NXP800, an oral small molecule inhibitor of the Heat Shock Factor 1 pathway, a signaling pathway in the initiation and progression of various cancers; and NXP900 program, an oral small molecule designed to inhibit the SRC and YES1 kinases. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Life Sciences Biology Treatment Of Cancer Tyrosine Kinase Oncogenes Cancer Research Kinase Small Molecule Proto Oncogene Tyrosine Protein Kinase Src

Is NVCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.9
52 Week Low 3.08
Average Volume 108,464
200-Day Moving Average 0.00
50-Day Moving Average 9.96
20-Day Moving Average 12.56
10-Day Moving Average 15.63
Average True Range 1.94
RSI 73.47
ADX 48.82
+DI 41.21
-DI 6.85
Chandelier Exit (Long, 3 ATRs) 14.09
Chandelier Exit (Short, 3 ATRs) 14.38
Upper Bollinger Bands 19.76
Lower Bollinger Band 5.35
Percent B (%b) 0.95
BandWidth 114.72
MACD Line 2.46
MACD Signal Line 1.75
MACD Histogram 0.7128
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.51
Resistance 3 (R3) 20.57 20.13 20.26
Resistance 2 (R2) 20.13 19.74 20.10 20.18
Resistance 1 (R1) 19.56 19.50 19.34 19.50 20.09
Pivot Point 19.12 19.12 19.01 19.09 19.12
Support 1 (S1) 18.56 18.73 18.33 18.50 17.91
Support 2 (S2) 18.11 18.50 18.08 17.82
Support 3 (S3) 17.55 18.11 17.74
Support 4 (S4) 17.49